Gino J. DiSciullo, Ph.D.

Gino J. DiSciullo, Ph.D.

Gino J. DiSciullo, Ph.D.

CEO
Prevacept Infection Control, Inc.

Gino J DiSciullo is CEO of Prevacept Infection Control, Inc. located in Broomfield Colorado and is a Partner at Charter Life Sciences, a healthcare venture capital firm based in Silicon Valley that invests in early stage therapeutics and healthcare IT companies. DiSciullo holds a doctorate pathology and has spent his career working early stage healthcare technology companies. He is also presently serving as a board member to Neuraptive Therapeutics Inc. (Lafayette, CO) and ClinOne, Inc. (Denver, CO) and is an advisor for DZee Solutions, Inc. (Centennial, CO) and HealthSqyre, Inc. (Denver, CO).